CLINICAL CHARACTERISTICS OF MEIBOMIAN GLAND DYSFUNCTION IN PATIENTS WITH PRIMARY SJÖGREN’S SYNDROME DRY EYE DISEASE

Thị Thu Hồng Võ , Thị Ngọc Anh Đầu, Thị Minh Tuệ Đặng, Thu Trang Nguyễn

Main Article Content

Abstract

Objectives: Describe the clinical characteristics of meibomian gland dysfunction (MGD) in dry eye patients with primary Sjögren’s syndrome (pSS) and review the association between meibomian gland dysfunction and dry eye disease in patients with primary Sjögren’s syndrome. Subjects and methods: Case study research is conducted in 20 dry eye patients (40 eyes) with pSS at the Cornea Department of Vietnam National Eye Hospital. Results: The average age of the patients is 53,2 ± 11,7, female – to – male ratio is of 9/1. Function of meibomian glands is disordered at many levels: change in lid morphology (thick lid margin: 55%, lid margin hyperemia: 50%, meibomian orifice plug: 42,5%); expressibility of meibomian glands is principally grade 1 (50%) and grade 2 (37,5%); quality of expressed lipid is mostly cloudy fluid (57,5%); meibomian gland dropout from grade 1 or higher accounts for 90%. Dry eye severity level has association with expressibility of meibomian gland. There is no relationship between dry eye severity level and quality of expressed lipid, meibomian gland dropout level. There is no relationship between MGD severity level and dry eye severity levels. Conclusions: pSS patients express various levels of MGD. There is no clear association between MGD and dry eye in pSS patients.

Article Details

References

Trần Thị Hương Trà, Đặng Thị Minh Tuệ. Đặc điểm khô mắt trên bệnh nhân mắc hội chứng Sjögren nguyên phát. Tạp chí Y học Việt Nam. 2022;511(1):173.
2. Arita R, Itoh K, Maeda S, Maeda K, Furuta A, Fukuoka S và các cộng sự. Proposed diagnostic criteria for obstructive meibomian gland dysfunction. Ophthalmology. 2009;116(11): 2058-63. e1.
3. Bodakçi E. Clinical and serological characteristics of anti-Ro/SS-A and anti-La/SS-B negative primary Sjögren's syndrome: a comparative study. European Review for Medical & Pharmacological Sciences. 2024;28(5).
4. Ramos-Casals M, Solans R, Rosas J, Camps MT, Gil A, del Pino-Montes J và các cộng sự. Primary Sjögren syndrome in Spain: clinical and immunologic expression in 1010 patients. Medicine. 2008;87(4):210-9.
5. Schaumberg DA, Nichols JJ, Papas EB, Tong L, Uchino M, Nichols KK. The international workshop on meibomian gland dysfunction: report of the subcommittee on the epidemiology of, and associated risk factors for, MGD. Invest Ophthalmol Vis Sci. 2011;52(4):1994-2005.
6. Sullivan DA, Dana R, Sullivan RM, Krenzer KL, Sahin A, Arica B và các cộng sự. Meibomian Gland Dysfunction in Primary and Secondary Sjogren Syndrome. Ophthalmic Res. 2018; 59(4):193-205.
7. Villani E, Beretta S, De Capitani M, Galimberti D, Viola F, Ratiglia R. In vivo confocal microscopy of meibomian glands in Sjögren's syndrome. Investigative ophthalmology & visual science. 2011;52(2):933-9.